Institutional shares held 163 Million
0 calls
88.3K puts
Total value of holdings $378M
$0 calls
$204K puts
Market Cap $211M
90,909,800 Shares Out.
Institutional ownership 179.37%
# of Institutions 98


Latest Institutional Activity in AUTL

Top Purchases

Q2 2025
Health Invest Partners Ab Shares Held: 1.11M ($2.56M)
Q2 2025
Aubrey Capital Management LTD Shares Held: 452K ($1.05M)
Q2 2025
Privium Fund Management B.V. Shares Held: 294K ($682K)
Q2 2025
Avanza Fonder Ab Shares Held: 53.5K ($124K)
Q2 2025
Forefront Wealth Management Inc. Shares Held: 26.9K ($62.3K)

Top Sells

Q2 2025
Perpetual LTD Shares Held: 829K ($1.92M)
Q2 2025
Wealth Effects LLC Shares Held: 13.5K ($31.3K)
Q2 2025
Byrne Asset Management LLC Shares Held: 225 ($522)
Q1 2025
Affinity Asset Advisors, LLC Shares Held: 3.05M ($7.06M)
Q1 2025
Two Sigma Investments, LP Shares Held: 395K ($917K)

About AUTL

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which is in a Phase 1 clinical trial in pediatric patients with relapsed or refractory ALL; AUTO4, a programmed T cell investigational therapy for the treatment of peripheral T-cell lymphoma targeting TRBC1; AUTO6NG, a programmed T cell investigational therapy, which is in preclinical trail targeting GD2 in development for the treatment of neuroblastoma; and AUTO8, a product candidate that is in a Phase I clinical trial for multiple myeloma. It also focuses on developing AUTO5, a hematological product candidate, which is in preclinical development. The company was incorporated in 2014 and is headquartered in London, the United Kingdom.


Insider Transactions at AUTL

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
0 Shares
From 0 Insiders
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on AUTL

Follow Autolus Therapeutics plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AUTL shares.

Notify only if

Insider Trading

Get notified when an Autolus Therapeutics PLC insider buys or sells AUTL shares.

Notify only if

News

Receive news related to Autolus Therapeutics plc

Track Activities on AUTL